-- 加拿大帝国商业银行资本市场(CIBC Capital Markets)将Choice Properties REIT (CHP-UN.TO)的评级上调至“跑赢大盘”,并维持16.50加元的目标价。 分析师Tal Woolley写道,自大约两周前宣布收购First Capital REIT (FCR-UN.TO)价值50亿加元的资产以来,Choice的股价下跌了6%,而同期零售REITs上涨了2%,所有REITs则持平。 他补充道:“虽然这笔交易会使年度化FFO/u(单位FFO)稀释3%,但合并后的投资组合质量更高,预计整体有机增长率也将有所提高,因此相对于同行而言,股价的回调幅度似乎过大。”他还指出,Choice的盈利能力仍然可预测。 收购First Capital会提高杠杆率,但杠杆率可以降低,而且Choice Properties在降低杠杆方面有着成功的记录。因此,Woolley认为,略微提高市盈率,即使盈利略微下降,也是合理的。 “预计总回报率约为15%,已从我们零售房地产投资信托基金覆盖范围的平均水平跃升至高端(范围:0%-15%,平均8%),因此我们上调了评级。” 16.50美元的目标价基于2027年预期FFO/单位15.1倍(此前为14.5倍),相当于一年后净资产值估值的10%溢价(此前为8%)。“这在其同业公司中处于高端水平,但我们认为,鉴于CHP较低的杠杆率、可观的增长和稳定的运营业绩,这一估值是合理的。” 加拿大帝国商业银行(CIBC)预计First Capital的收购交易将于第四季度完成。
Related Articles
Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.
Comfort Systems USA Insider Sold Shares Worth $889,890, According to a Recent SEC Filing
Pablo G. Mercado, Director, on April 30, 2026, sold 500 shares in Comfort Systems USA (FIX) for $889,890. Following the Form 4 filing with the SEC, Mercado has control over a total of 3,000 common shares of the company, with 3,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035983/000153524626000004/xslF345X05/form4-05012026_040501.xml
Kaiser Aluminum Insider Sold Shares Worth $524,757, According to a Recent SEC Filing
Keith Harvey, Director, President & CEO, on April 29, 2026, sold 3,031 shares in Kaiser Aluminum (KALU) for $524,757. Following the Form 4 filing with the SEC, Harvey has control over a total of 94,308 common shares of the company, with 94,308 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/811596/000119312526201545/xslF345X05/ownership.xml